![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Bladder Cancer |
Free Subscription
1 Am J Surg Pathol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
Nested Subtype of Urothelial Carcinoma in the Upper Urinary Tract: A Series of 15
Cases.
Am J Surg Pathol. 2023;47:461-468.
PubMed
Abstract available
ASO Author Reflections: Is T1HG Bladder Cancer a Good Candidate for En Bloc
Resection?
Ann Surg Oncol. 2023 Mar 12. doi: 10.1245/s10434-023-13291.
PubMed
Efficacy and safety of enfortumab vedotin in the treatment of advanced urothelial
carcinoma: a systematic review and meta-analysis.
Anticancer Drugs. 2023;34:473-478.
PubMed
Abstract available
Complete response to tislelizumab in a metastatic urothelial carcinoma after
surgery associated with high tumor mutational burden: a case report.
Anticancer Drugs. 2023;34:595-598.
PubMed
Abstract available
Fibronectin-1: A Predictive Immunotherapy Response Biomarker for Muscle‑Invasive
Bladder Cancer.
Arch Esp Urol. 2023;76:70-83.
PubMed
Abstract available
Predicting bladder cancer risk in patients with hematuria. A single-centre
retrospective study.
Arch Ital Urol Androl. 2023 Mar 15. doi: 10.4081/aiua.2023.11026.
PubMed
Abstract available
Anthropometric characteristics and relationship with non-muscle invasive bladder
cancer in Greece: A case-control study.
Arch Ital Urol Androl. 2023 Mar 15. doi: 10.4081/aiua.2023.11266.
PubMed
Abstract available
A novel microfluidic system for enrichment of functional circulating tumor cells
in cancer patient blood samples by combining cell size and invasiveness.
Biosens Bioelectron. 2023;227:115159.
PubMed
Abstract available
Effective-by-method for the preparation of folic acid coated TiO(2) nanoparticles
with high targeting potential for apoptosis induction against bladder cancer
cells (T24).
Biotechnol Appl Biochem. 2023 Mar 11. doi: 10.1002/bab.2456.
PubMed
Abstract available
SNHG18 inhibits bladder cancer cell proliferation by increasing p21 transcription
through destabilizing c-Myc protein.
Cancer Cell Int. 2023;23:48.
PubMed
Abstract available
Tumour microenvironment as a predictive factor for immunotherapy in
non-muscle-invasive bladder cancer.
Cancer Immunol Immunother. 2023 Mar 16. doi: 10.1007/s00262-023-03376.
PubMed
Abstract available
Multiple directional DWI combined with T2WI in predicting muscle layer and Ki-67
correlation in bladder cancer in 3.0-T MRI.
Cancer Med. 2023 Mar 14. doi: 10.1002/cam4.5782.
PubMed
Abstract available
Role of FGFR3 in bladder cancer: Treatment landscape and future challenges.
Cancer Treat Rev. 2023;115:102530.
PubMed
Abstract available
Correction: Zhu et al. A Feedback Loop Formed by ATG7/Autophagy, FOXO3a/miR-145
and PD-L1 Regulates Stem-like Properties and Invasion in Human Bladder Cancer.
Cancers 2019, 11, 349.
Cancers (Basel). 2023;15:1403.
PubMed
Abstract available
Evaluating the Protective Effect of Intravesical Bacillus Calmette-Guerin against
SARS-CoV-2 in Non-Muscle Invasive Bladder Cancer Patients: A Multicenter
Observational Trial.
Cancers (Basel). 2023;15:1618.
PubMed
Abstract available
A Comprehensive Analysis of Immune Response in Patients with Non-Muscle-Invasive
Bladder Cancer.
Cancers (Basel). 2023;15:1364.
PubMed
Abstract available
Robotic Radical Cystectomy with Intracorporeal Urinary Diversion - Tips and
Tricks.
Chirurgia (Bucur). 2023;118:63-72.
PubMed
Abstract available
Added Clinical Value of (18)F-FDG-PET/CT to Stage Patients With High-Risk
Non-Muscle Invasive Bladder Cancer Before Radical Cystectomy.
Clin Genitourin Cancer. 2023 Feb 22:S1558-7673(23)00037.
PubMed
Abstract available
Differences in Quality of Life and Toxicity for Male and Female Patients
following Chemo(radiotherapy) for Bladder Cancer.
Clin Oncol (R Coll Radiol). 2023 Feb 11:S0936-6555(23)00052.
PubMed
Abstract available
Comput Methods Programs Biomed
Predicting muscle invasion in bladder cancer based on MRI: A comparison of
radiomics, and single-task and multi-task deep learning.
Comput Methods Programs Biomed. 2023;233:107466.
PubMed
Abstract available
Clinical Characteristics and Current Status of Treatment for Recurrent Bladder
Cancer after Surgeries on Upper Tract Urothelial Carcinoma.
Diagnostics (Basel). 2023;13:1004.
PubMed
Abstract available
UCseek: ultrasensitive early detection and recurrence monitoring of urothelial
carcinoma by shallow-depth genome-wide bisulfite sequencing of urinary sediment
DNA.
EBioMedicine. 2023;89:104437.
PubMed
Abstract available
Patient-reported Outcomes from JAVELIN Bladder 100: Avelumab First-line
Maintenance Plus Best Supportive Care Versus Best Supportive Care Alone for
Advanced Urothelial Carcinoma.
Eur Urol. 2023;83:320-328.
PubMed
Abstract available
Time to Rethink Quality of Life Assessment in Patients with Urothelial Cancer in
the Current Therapeutic Era?
Eur Urol. 2023;83:329-330.
PubMed
In Patients with Advanced Urothelial Carcinoma, Immune Checkpoint Inhibition
Prior to Enfortumab Vedotin Is Associated with High-grade Skin Toxicity.
Eur Urol. 2023;83:377-378.
PubMed
ADAPT and Improvise: Overcoming Bacillus Calmette-Guerin Unresponsiveness in
Non-muscle-invasive Bladder Cancer.
Eur Urol. 2023 Mar 8:S0302-2838(23)02627-1. doi: 10.1016/j.eururo.2023.
PubMed
Corrigendum to "Assessment of Predictive Genomic Biomarkers for Response to
Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer" [Eur Urol
2023;83:313-17].
Eur Urol. 2023 Mar 10:S0302-2838(23)02641-6. doi: 10.1016/j.eururo.2023.
PubMed
A Systematic Review of Oncological Outcomes Associated with Bladder-sparing
Strategies in Patients Achieving Complete Clinical Response to Initial Systemic
Treatment for Localized Muscle-invasive Bladder Cancer.
Eur Urol Oncol. 2023 Mar 9:S2588-9311(23)00040-8. doi: 10.1016/j.euo.2023.
PubMed
Abstract available
Identification of a glutamine metabolism reprogramming signature for predicting
prognosis, immunotherapy efficacy, and drug candidates in bladder cancer.
Front Immunol. 2023;14:1111319.
PubMed
Abstract available
Association of regional anesthesia with oncological outcomes in patients
receiving surgery for bladder cancer: A meta-analysis of observational studies.
Front Oncol. 2023;13:1097637.
PubMed
Abstract available
Trends and risk factors of global incidence, mortality, and disability of
genitourinary cancers from 1990 to 2019: Systematic analysis for the Global
Burden of Disease Study 2019.
Front Public Health. 2023;11:1119374.
PubMed
Abstract available
Prognostic nomogram for estimating survival in patients with resected
muscle-invasive bladder cancer receiving chemotherapy.
Front Surg. 2023;10:1121184.
PubMed
Abstract available
Methylation analysis of histone 4-related gene HIST1H4F and its effect on gene
expression in bladder cancer.
Gene. 2023;866:147352.
PubMed
Abstract available
Glutathione S-transferase zeta 1 alters the HMGB1/GPX4 axis to drive ferroptosis
in bladder cancer cells.
Hum Exp Toxicol. 2023;42:9603271231161606.
PubMed
Abstract available
Focus on the Use of Resveratrol in Bladder Cancer.
Int J Mol Sci. 2023;24:4562.
PubMed
Abstract available
Emerging RNA-Based Therapeutic and Diagnostic Options: Recent Advances and Future
Challenges in Genitourinary Cancers.
Int J Mol Sci. 2023;24:4601.
PubMed
Abstract available
Crosstalk between Mesenchymal Stem Cells and Cancer Stem Cells Reveals a Novel
Stemness-Related Signature to Predict Prognosis and Immunotherapy Responses for
Bladder Cancer Patients.
Int J Mol Sci. 2023;24:4760.
PubMed
Abstract available
Association of SNPs in the PAI1 Gene with Disease Recurrence and Clinical Outcome
in Bladder Cancer.
Int J Mol Sci. 2023;24:4943.
PubMed
Abstract available
Editorial Comment on Validation of the risk stratification newly defined in the
Japanese Urological Association guidelines 2019 for non-muscle invasive bladder
cancer: A multi-institutional collaborative study.
Int J Urol. 2023 Mar 16. doi: 10.1111/iju.15177.
PubMed
The Effect of Sex on Disease Stage and Survival after Radical Cystectomy in
Non-Urothelial Variant-Histology Bladder Cancer.
J Clin Med. 2023;12:1776.
PubMed
Abstract available
Clinical Significance and Tumor Microenvironment Characterization of a Novel
Immune-Related Gene Signature in Bladder Cancer.
J Clin Med. 2023;12:1892.
PubMed
Abstract available
J Laparoendosc Adv Surg Tech A
Application of Transvaginal Natural Orifice Specimen Extraction Surgery in
Urological Surgery.
J Laparoendosc Adv Surg Tech A. 2023;33:231-235.
PubMed
Abstract available
Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of
Cxbladder Tests and Improves Patient Risk Stratification. Letter.
J Urol. 2023;209:676-677.
PubMed
Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of
Cxbladder Tests and Improves Patient Risk Stratification.
J Urol. 2023;209:762-772.
PubMed
Abstract available
Prognostic factors and nomogram for the overall survival of bladder cancer bone
metastasis: A SEER-based study.
Medicine (Baltimore). 2023;102:e33275.
PubMed
Abstract available
LncRNA JHDM1D-AS1 Is a Key Biomarker for Progression and Modulation of
Gemcitabine Sensitivity in Bladder Cancer Cells.
Molecules. 2023;28:2412.
PubMed
Abstract available
Global trends in the epidemiology of bladder cancer: challenges for public health
and clinical practice.
Nat Rev Clin Oncol. 2023 Mar 13. doi: 10.1038/s41571-023-00744.
PubMed
Abstract available
Naunyn Schmiedebergs Arch Pharmacol
Nitidine chloride regulates cell function of bladder cancer in vitro through
downregulating Lymphocyte antigen 75.
Naunyn Schmiedebergs Arch Pharmacol. 2023.
PubMed
Abstract available
Robot-assisted laparoscopic cystectomy with non-continent urinary diversion for
neurogenic lower urinary tract dysfunction: Midterm outcomes.
Neurourol Urodyn. 2023;42:586-596.
PubMed
Abstract available
MiR-9 promotes proliferation and inhibits apoptosis of bladder cancer cells via
notch signaling pathway.
Panminerva Med. 2023;65:114-115.
PubMed
Urachal carcinoma: The journey so far and the road ahead.
Pathol Res Pract. 2023;243:154379.
PubMed
Abstract available
[Evaluation of the efficacy and safety of HIVEC intravesical thermochemotherapy
with intermediate-risk and high-risk non-muscle-invasive bladder cancer].
Prog Urol. 2023 Mar 9:S1166-7087(23)00062-3. doi: 10.1016/j.purol.2023.
PubMed
Abstract available
An m7G-related lncRNA signature predicts prognosis and reveals the immune
microenvironment in bladder cancer.
Sci Rep. 2023;13:4302.
PubMed
Abstract available
Recreating heterogeneity of bladder cancer microenvironment to study its
recurrences and progression.
Stem Cell Investig. 2023;10:5.
PubMed
Effect of isorhamnetin on carbonic anhydrase IX expression and tumorigenesis of
bladder cancer by activating PPARgamma/PTEN/AKT pathway.
Tissue Cell. 2023;82:102048.
PubMed
Abstract available
Exosomal miR-93-5p as an important driver of bladder cancer progression.
Transl Androl Urol. 2023;12:286-299.
PubMed
Abstract available
Identification and validation of immunohistochemical marker panels to predict the
prognosis of muscle invasive bladder cancer.
Transl Androl Urol. 2023;12:176-186.
PubMed
Abstract available
Neoadjuvant and adjuvant chemotherapy share equivalent efficacy in improving
overall survival and cancer-specific survival among muscle invasive bladder
cancer patients who undergo radical cystectomy: a retrospective cohort study
based on SEER databas
Transl Androl Urol. 2023;12:330-346.
PubMed
Abstract available
Prognostic value of galectin-1 and galectin-3 expression in localized urothelial
bladder cancer.
Transl Androl Urol. 2023;12:228-240.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by